Risk Flags
extreme_brand_preference
Risk indicators are statistical patterns, not allegations. Learn more
265,828
Total Claims
$63.2M
Drug Cost
187,402
Beneficiaries
$337
Cost/Patient
Risk Score Breakdown 9/100
Low (0)Moderate (15)Elevated (30)High (50+)
Brand-name preference+8
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-68%
Cost per patient vs peers
$337 vs $1,068 avg
+1008%
Brand preference vs peers
99.7% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
0% generic
Brand: 265,097 claims · $63.2M
Generic: 712 claims · $13K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rsvpref3 Antigen/As01e/Pf | 87,363 | $26.8M |
| Varicella-Zoster Ge/As01b/Pf | 94,485 | $19.9M |
| Rsv Vacc, Pref A And Pref B/Pf | 38,818 | $12.3M |
| Hepatitis A And B Vaccine/Pf | 12,583 | $1.8M |
| Diphth,pertuss(Acell),tet Vac | 24,025 | $1.6M |
| Hepatitis A Virus Vaccine/Pf | 3,360 | $341K |
| Diph,pertuss(Acell),tet Vac/Pf | 2,169 | $148K |
| Measles,mumps,rubella Vacc/Pf | 493 | $56K |
| Hpv Vaccine 9-Valent/Pf | 125 | $38K |
| Tetanus-Diphtheria Toxoids/Pf | 609 | $37K |
| Hepatitis A Virus Vaccine/Pf | 338 | $32K |
| Typhoid Vi Polysacch Vaccine | 217 | $29K |
| Mening Vac A,c,y,w135,c-Tet/Pf | 72 | $13K |
| Hepatitis B Vaccine/Cpg1018/Pf | 77 | $12K |
| Exenatide Microspheres | 12 | $10K |
Prescribing Profile
41
Unique Drugs
9.0
Anomaly Score
Patient Profile
74
Avg Age
57%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About